{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:01:56Z","timestamp":1785787316552,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60714-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:15:39Z","timestamp":1751354139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Increase in H5N1 vaccine antibodies confers cross-neutralization of highly pathogenic avian influenza H5N1"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiande","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4990-1016","authenticated-orcid":false,"given":"Dayan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1807-314X","authenticated-orcid":false,"given":"Chenyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4246-8889","authenticated-orcid":false,"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"60714_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41579-024-01087-1","volume":"22","author":"G Neumann","year":"2024","unstructured":"Neumann, G. & Kawaoka, Y. Highly pathogenic H5N1 avian influenza virus outbreak in cattle: the knowns and unknowns. Nat. Rev. Microbiol. 22, 525\u2013526 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"60714_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imj.2024.100108","volume":"3","author":"N Sevilla","year":"2024","unstructured":"Sevilla, N. et al. Highly pathogenic avian influenza A (H5N1) virus outbreak in Peru in 2022\u20132023. Infect. Med. 3, 100108 (2024).","journal-title":"Infect. Med."},{"key":"60714_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3201\/eid3007.240508","volume":"30","author":"E Burrough","year":"2024","unstructured":"Burrough, E. et al. Highly pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b virus infection in domestic dairy cattle and cats, United States, 2024. Emerg. Infect. Dis. J. 30, 1335 (2024).","journal-title":"Emerg. Infect. Dis. J."},{"key":"60714_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3201\/eid3003.231098","volume":"30","author":"P Plaza","year":"2024","unstructured":"Plaza, P., Gamarra-Toledo, V., Eugu\u00ed, J. R. & Lambertucci, S. Recent changes in patterns of mammal infection with highly pathogenic Avian Influenza A(H5N1) virus worldwide. Emerg. Infect. Dis. J. 30, 444 (2024).","journal-title":"Emerg. Infect. Dis. J."},{"key":"60714_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-024-07766-6","volume":"633","author":"AJ Eisfeld","year":"2024","unstructured":"Eisfeld, A. J. et al. Pathogenicity and transmissibility of bovine H5N1 influenza virus. Nature 633, 426\u2013432 (2024).","journal-title":"Nature"},{"key":"60714_CR6","doi-asserted-by":"publisher","first-page":"a038489","DOI":"10.1101\/cshperspect.a038489","volume":"10","author":"M Wille","year":"2020","unstructured":"Wille, M. & Holmes, E. C. The ecology and evolution of Influenza viruses. Cold Spring Harb. Perspect. Med 10, a038489 (2020).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"60714_CR7","first-page":"408","volume":"35","author":"F Deng","year":"2024","unstructured":"Deng, F. et al. Molecular characteristics of the first human case infected with the avian influenza virus H5N1 clade 2.3.3.4b in eastern China. Jiangsu J. Prev. Med. 35, 408\u2013411 (2024).","journal-title":"Jiangsu J. Prev. Med."},{"key":"60714_CR8","doi-asserted-by":"publisher","first-page":"e02315","DOI":"10.1128\/spectrum.02315-22","volume":"10","author":"X Ke","year":"2022","unstructured":"Ke, X. et al. Highly pathogenic Avian Influenza A (H5N1) virus in Swans, Central China, 2021. Microbiol. Spectr. 10, e02315\u2013e02322 (2022).","journal-title":"Microbiol. Spectr."},{"key":"60714_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/22221751.2021.1872355","volume":"10","author":"NS Lewis","year":"2021","unstructured":"Lewis, N. S. et al. Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020. Emerg. Microbes Infect. 10, 148\u2013151 (2021).","journal-title":"Emerg. Microbes Infect."},{"key":"60714_CR10","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/22221751.2022.2088407","volume":"11","author":"P Cui","year":"2022","unstructured":"Cui, P. et al. Global dissemination of H5N1 influenza viruses bearing the clade 2.3.4.4b HA gene and biological analysis of the ones detected in China. Emerg. Microbes Infect. 11, 1693\u20131704 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"60714_CR11","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3201\/eid2807.212482","volume":"28","author":"W Zhu","year":"2022","unstructured":"Zhu, W. et al. Epidemiologic, clinical, and genetic characteristics of human infections with Influenza A(H5N6) viruses, China. Emerg. Infect. Dis. J. 28, 1332 (2022).","journal-title":"Emerg. Infect. Dis. J."},{"key":"60714_CR12","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3390\/v13081657","volume":"13","author":"FS Oladunni","year":"2021","unstructured":"Oladunni, F. S., Oseni, S. O., Martinez-Sobrido, L. & Chambers, T. M. Equine Influenza virus and vaccines. Viruses 13, 1657 (2021).","journal-title":"Viruses"},{"key":"60714_CR13","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1086\/597401","volume":"48","author":"J Wu","year":"2009","unstructured":"Wu, J. et al. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial. Clin. Infect. Dis. 48, 1087\u20131095 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"60714_CR14","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1038\/s41591-024-03189-y","volume":"30","author":"S Khurana","year":"2024","unstructured":"Khurana, S. et al. Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus. Nat. Med. 30, 2771\u20132776 (2024).","journal-title":"Nat. Med."},{"key":"60714_CR15","doi-asserted-by":"crossref","unstructured":"Wang, Y. Pseudotyped Viruses (Springer Press, 2023).","DOI":"10.1007\/978-981-99-0113-5"},{"key":"60714_CR16","doi-asserted-by":"publisher","first-page":"2100439","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100439","volume":"26","author":"OG Pyankova","year":"2021","unstructured":"Pyankova, O. G. et al. Isolation of clade 2.3.4.4b A(H5N8), a highly pathogenic avian influenza virus, from a worker during an outbreak on a poultry farm, Russia, December 2020. Eurosurveillance 26, 2100439 (2021).","journal-title":"Eurosurveillance"},{"key":"60714_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26822-6","volume":"8","author":"Y Tian","year":"2018","unstructured":"Tian, Y. et al. Development of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus. Sci. Rep. 8, 8484 (2018).","journal-title":"Sci. Rep."},{"key":"60714_CR18","doi-asserted-by":"publisher","first-page":"2380111","DOI":"10.1080\/21645515.2024.2380111","volume":"20","author":"X Huang","year":"2024","unstructured":"Huang, X. et al. Neutralization potency of the 2023-24 seasonal influenza vaccine against circulating influenza H3N2 strains. Hum. Vaccines Immunother. 20, 2380111 (2024).","journal-title":"Hum. Vaccines Immunother."},{"key":"60714_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","volume":"35","author":"CW Potter","year":"1979","unstructured":"Potter, C. W. & Oxford, J. S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 35, 69\u201375 (1979).","journal-title":"Br. Med. Bull."},{"key":"60714_CR20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1128\/CVI.00278-15","volume":"22","author":"KL Laurie","year":"2015","unstructured":"Laurie, K. L. et al. International laboratory comparison of influenza microneutralization assays for A (H1N1) pdm09, A (H3N2), and A (H5N1) influenza viruses by CONSISE. Clin. Vaccin. Immunol. 22, 957\u2013964 (2015).","journal-title":"Clin. Vaccin. Immunol."},{"key":"60714_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1155552","volume":"14","author":"J Waldock","year":"2023","unstructured":"Waldock, J. et al. Haemagglutination inhibition and virus microneutralisation serology assays: Use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: a FLUCOP collaborative study. Front. Immunol. 14, 1155552 (2023).","journal-title":"Front. Immunol."},{"key":"60714_CR22","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","volume":"15","author":"J Nie","year":"2020","unstructured":"Nie, J. et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat. Protoc. 15, 3699\u20133715 (2020).","journal-title":"Nat. Protoc."},{"key":"60714_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep42769","volume":"7","author":"J Nie","year":"2017","unstructured":"Nie, J. et al. Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system. Sci. Rep. 7, 42769 (2017).","journal-title":"Sci. Rep."},{"key":"60714_CR24","doi-asserted-by":"publisher","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","volume":"79","author":"M Li","year":"2005","unstructured":"Li, M. et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108\u201310125 (2005).","journal-title":"J. Virol."},{"key":"60714_CR25","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","volume":"182","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell 182, 1284\u20131294 (2020).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60714-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:15:40Z","timestamp":1751354140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60714-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60714"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60714-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5475107\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5517"}}